WallStreetZenWallStreetZen

NASDAQ: TCRX
Tscan Therapeutics Inc Stock Ownership - Who owns Tscan Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tscan Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lynx1 Capital Management LP10% Owner2025-12-236,232$0.90
$5.60kBuy
Lynx1 Capital Management LP10% Owner2025-12-2275,500$0.90
$67.95kBuy
Lynx1 Capital Management LP10% Owner2025-12-1980,069$0.90
$71.98kBuy
Lynx1 Capital Management LP10% Owner2025-05-201,200,000$1.20
$1.44MBuy
Lynx1 Capital Management LP10% Owner2025-05-191,388,794$1.20
$1.67MBuy

1 of 1

TCRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TCRX insiders and whales buy or sell their stock.

TCRX Shareholders

What type of owners hold Tscan Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lynx1 Capital Management LP14.09%8,019,148$8.42MInsider
Lynx1 Capital Management LP14.09%8,019,148$8.42MInstitution
Bvf Inc9.18%5,226,074$5.49MInstitution
Ecor1 Capital LLC8.79%5,000,000$5.25MInsider
Baker Bros Advisors LP4.89%2,784,792$2.92MInstitution
Baker Bros Advisors LP4.44%2,528,583$2.66MInsider
Vanguard Group Inc4.35%2,475,733$2.60MInstitution
Blackrock Inc3.25%1,848,695$1.94MInstitution
Aberdeen Group PLC3.14%1,785,241$1.87MInstitution
Deer Management Co LLC2.19%1,245,504$1.31MInstitution

1 of 3

TCRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TCRX53.94%29.91%Net BuyingNet Buying
EXOZ0.46%99.54%Net Buying
CLNN6.83%93.17%Net SellingNet Buying
IFRX28.59%0.00%
ENTX20.33%16.86%Net BuyingNet Buying
View Top Biotech Stocks

Tscan Therapeutics Stock Ownership FAQ

Who owns Tscan Therapeutics?

Tscan Therapeutics (NASDAQ: TCRX) is owned by 53.94% institutional shareholders, 29.91% Tscan Therapeutics insiders, and 16.14% retail investors. Lynx1 Capital Management LP is the largest individual Tscan Therapeutics shareholder, owning 8.02M shares representing 14.09% of the company. Lynx1 Capital Management LP's Tscan Therapeutics shares are currently valued at $8.50M.

If you're new to stock investing, here's how to buy Tscan Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.